Daniel W. Coyne - Concepedia

Author

Daniel W. Coyne

Washington University in St. Louis ORCID

Also Known As

Coyne, D.W., D Coyne, D W Coyne, D. Coyne, D. W. Coyne, D.W. Coyne, Daniel Coyne, Daniel W Coyne, Daniel W. COYNE, Daniel W. Coyne

188

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Indiana University – Purdue University Indianapolis Indiana University School of Medicine Harvard University Stanford University

About

Daniel W. Coyne is an author at Washington University in St. Louis specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	3.2K
2	Public Health	4	4	630
3	Health Sciences	3	3	60
4	Biochemistry	3	3	52
5	Natural Sciences	1	1	10

Daniel W. Coyne

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis Geoffrey A. Block, Kévin Martin, Ángel Francisco, New England Journal of Medicine	2004	1.1K
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl, The Lancet Renal FunctionVital StudyDiabetesPharmacologyType 2	2010	686
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States Rajiv Agarwal, Allen R. Nissenson, Daniel Batlle, The American Journal of Medicine HypertensionUrologyHemodialysisCardiovascular DiseaseHealth Policy	2003	475
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, Kidney International	2016	468
Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin Saturation Daniel W. Coyne, Toros Kapoian, Wadi N. Suki, Journal of the American Society of Nephrology HemodialysisUrologyRenal FunctionIron MetabolismKidney Failure	2007	390
Increased Plasma Leptin Concentration in End-Stage Renal Disease1 Eddine K. Merabet, Samuel Dagogo‐Jack, Daniel W. Coyne, The Journal of Clinical Endocrinology & Metabolism	1997	232
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD Daniel W. Coyne, Muralidhar Acharya, Ping Qiu, American Journal of Kidney Diseases Secondary HyperparathyroidismUrologyStages 3Paricalcitol CapsuleParathyroid Hormone	2006	226
Impact of Dialysis Dose and Membrane on Infection-Related Hospitalization and Death Michael Allon, Thomas A. Depner, Milena Radeva, Journal of the American Society of Nephrology	2003	213
Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran Beckie Michael, Daniel W. Coyne, Steven Fishbane, Kidney International HemodialysisUrologyRenal FunctionHemodialysis PatientsKidney Failure	2002	204
Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin Toros Kapoian, Neeta Bahal O’Mara, Ajay Singh, Journal of the American Society of Nephrology HemodialysisUrologyRenal FunctionHemodialysis PatientsKidney Failure	2008	183

Page 1